Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Implementing Morpholino-Based Nucleic Acid Sensing on a Portable Surface Plasmon Resonance Instrument for Future Application in Environmental Monitoring.

Bagi A, Soelberg SD, Furlong CE, Baussant T.

Sensors (Basel). 2018 Sep 28;18(10). pii: E3259. doi: 10.3390/s18103259.

2.

Ancient convergent losses of Paraoxonase 1 yield potential risks for modern marine mammals.

Meyer WK, Jamison J, Richter R, Woods SE, Partha R, Kowalczyk A, Kronk C, Chikina M, Bonde RK, Crocker DE, Gaspard J, Lanyon JM, Marsillach J, Furlong CE, Clark NL.

Science. 2018 Aug 10;361(6402):591-594. doi: 10.1126/science.aap7714.

PMID:
30093596
3.

Metals and Paraoxonases.

Costa LG, Cole TB, Garrick JM, Marsillach J, Furlong CE.

Adv Neurobiol. 2017;18:85-111. doi: 10.1007/978-3-319-60189-2_5. Review.

PMID:
28889264
4.

Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals.

Holzinger ER, Verma SS, Moore CB, Hall M, De R, Gilbert-Diamond D, Lanktree MB, Pankratz N, Amuzu A, Burt A, Dale C, Dudek S, Furlong CE, Gaunt TR, Kim DS, Riess H, Sivapalaratnam S, Tragante V, van Iperen EPA, Brautbar A, Carrell DS, Crosslin DR, Jarvik GP, Kuivaniemi H, Kullo IJ, Larson EB, Rasmussen-Torvik LJ, Tromp G, Baumert J, Cruickshanks KJ, Farrall M, Hingorani AD, Hovingh GK, Kleber ME, Klein BE, Klein R, Koenig W, Lange LA, Mӓrz W, North KE, Charlotte Onland-Moret N, Reiner AP, Talmud PJ, van der Schouw YT, Wilson JG, Kivimaki M, Kumari M, Moore JH, Drenos F, Asselbergs FW, Keating BJ, Ritchie MD.

BioData Min. 2017 Jul 24;10:25. doi: 10.1186/s13040-017-0145-5. eCollection 2017.

5.

Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.

Souza-Nogueira A, Camargo AE, Remondi FA, Paoliello MM, Richter RJ, Furlong CE, Barbosa DS, Maes M, Moreira EG.

Arch Endocrinol Metab. 2016 Oct;60(5):426-435. doi: 10.1590/2359-3997000000184. Epub 2016 Aug 25.

6.

Paraoxonase-1 and Early-Life Environmental Exposures.

Marsillach J, Costa LG, Furlong CE.

Ann Glob Health. 2016 Jan-Feb;82(1):100-10. doi: 10.1016/j.aogh.2016.01.009. Review.

7.

Paraoxonases-1, -2 and -3: What are their functions?

Furlong CE, Marsillach J, Jarvik GP, Costa LG.

Chem Biol Interact. 2016 Nov 25;259(Pt B):51-62. doi: 10.1016/j.cbi.2016.05.036. Epub 2016 May 26.

8.

Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA).

Kim DS, Li YK, Bell GA, Burt AA, Vaisar T, Hutchins PM, Furlong CE, Otvos JD, Polak JF, Arnan MK, Kaufman JD, McClelland RL, Longstreth WT Jr, Jarvik GP.

J Am Heart Assoc. 2016 May 20;5(5). pii: e002977. doi: 10.1161/JAHA.115.002977.

9.

Developmental expression of paraoxonase 2.

Garrick JM, Dao K, de Laat R, Elsworth J, Cole TB, Marsillach J, Furlong CE, Costa LG.

Chem Biol Interact. 2016 Nov 25;259(Pt B):168-174. doi: 10.1016/j.cbi.2016.04.001. Epub 2016 Apr 7.

10.

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Kim DS, Burt AA, Ranchalis JE, Vuletic S, Vaisar T, Li WF, Rosenthal EA, Dong W, Eintracht JF, Motulsky AG, Brunzell JD, Albers JJ, Furlong CE, Jarvik GP.

J Lipid Res. 2015 Jul;56(7):1351-62. doi: 10.1194/jlr.P058032. Epub 2015 May 25.

11.

Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.

Marsillach J, Becker JO, Vaisar T, Hahn BH, Brunzell JD, Furlong CE, de Boer IH, McMahon MA, Hoofnagle AN; DCCT/EDIC Research Group.

J Proteome Res. 2015 May 1;14(5):2046-54. doi: 10.1021/pr5011586. Epub 2015 Mar 13.

12.

Human valacyclovir hydrolase/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase.

Marsillach J, Suzuki SM, Richter RJ, McDonald MG, Rademacher PM, MacCoss MJ, Hsieh EJ, Rettie AE, Furlong CE.

PLoS One. 2014 Oct 15;9(10):e110054. doi: 10.1371/journal.pone.0110054. eCollection 2014.

13.

Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants.

Kim DS, Burt AA, Ranchalis JE, Jarvik LE, Eintracht JF, Furlong CE, Jarvik GP.

Nutr Metab (Lond). 2014 Sep 15;11(1):44. doi: 10.1186/1743-7075-11-44. eCollection 2014.

14.

Repeated gestational exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1) modulated effects in maternal and fetal tissues.

Cole TB, Li WF, Co AL, Hay AM, MacDonald JW, Bammler TK, Farin FM, Costa LG, Furlong CE.

Toxicol Sci. 2014 Oct;141(2):409-22. doi: 10.1093/toxsci/kfu144. Epub 2014 Jul 28.

15.

HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants.

Kim DS, Burt AA, Rosenthal EA, Ranchalis JE, Eintracht JF, Hatsukami TS, Furlong CE, Marcovina S, Albers JJ, Jarvik GP.

J Am Heart Assoc. 2014 Jun 25;3(3):e000902. doi: 10.1161/JAHA.114.000902.

16.

Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.

Kim DS, Crosslin DR, Auer PL, Suzuki SM, Marsillach J, Burt AA, Gordon AS, Meschia JF, Nalls MA, Worrall BB, Longstreth WT Jr, Gottesman RF, Furlong CE, Peters U, Rich SS, Nickerson DA, Jarvik GP; NHLBI Exome Sequencing Project.

J Lipid Res. 2014 Jun;55(6):1173-8. doi: 10.1194/jlr.P049247. Epub 2014 Apr 7.

17.

Semi-automated, occupationally safe immunofluorescence microtip sensor for rapid detection of Mycobacterium cells in sputum.

Inoue S, Becker AL, Kim JH, Shu Z, Soelberg SD, Weigel KM, Hiraiwa M, Cairns A, Lee HB, Furlong CE, Oh K, Lee KH, Gao D, Chung JH, Cangelosi GA.

PLoS One. 2014 Jan 22;9(1):e86018. doi: 10.1371/journal.pone.0086018. eCollection 2014.

18.

Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects.

Kim DS, Maden SK, Burt AA, Ranchalis JE, Furlong CE, Jarvik GP.

Lipids Health Dis. 2013 Dec 12;12:183. doi: 10.1186/1476-511X-12-183.

19.

Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Kim DS, Marsillach J, Furlong CE, Jarvik GP.

Pharmacogenomics. 2013 Sep;14(12):1495-515. doi: 10.2217/pgs.13.147. Review.

20.

Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Costa LG, de Laat R, Dao K, Pellacani C, Cole TB, Furlong CE.

Neurotoxicology. 2014 Jul;43:3-9. doi: 10.1016/j.neuro.2013.08.011. Epub 2013 Sep 4. Review.

21.

Microfluidic one-step synthesis of alginate microspheres immobilized with antibodies.

Chen W, Kim JH, Zhang D, Lee KH, Cangelosi GA, Soelberg SD, Furlong CE, Chung JH, Shen AQ.

J R Soc Interface. 2013 Aug 21;10(88):20130566. doi: 10.1098/rsif.2013.0566. Print 2013 Nov 6.

22.

Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection?

Costa LG, Tait L, de Laat R, Dao K, Giordano G, Pellacani C, Cole TB, Furlong CE.

Neurochem Res. 2013 Sep;38(9):1809-18. doi: 10.1007/s11064-013-1085-1. Epub 2013 Jun 7.

23.

Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.

Kim DS, Burt AA, Ranchalis JE, Jarvik ER, Rosenthal EA, Hatsukami TS, Furlong CE, Jarvik GP.

J Lipid Res. 2013 May;54(5):1512-20. doi: 10.1194/jlr.P035238. Epub 2013 Mar 11.

24.

Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression.

Giordano G, Tait L, Furlong CE, Cole TB, Kavanagh TJ, Costa LG.

Free Radic Biol Med. 2013 May;58:98-108. doi: 10.1016/j.freeradbiomed.2013.01.019. Epub 2013 Jan 30.

25.

Loci influencing blood pressure identified using a cardiovascular gene-centric array.

Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA, Barnard J, Baumert J, Chang YP, Elbers CC, Farrall M, Fischer ME, Franceschini N, Gaunt TR, Gho JM, Gieger C, Gong Y, Isaacs A, Kleber ME, Mateo Leach I, McDonough CW, Meijs MF, Mellander O, Molony CM, Nolte IM, Padmanabhan S, Price TS, Rajagopalan R, Shaffer J, Shah S, Shen H, Soranzo N, van der Most PJ, Van Iperen EP, Van Setten J, Vonk JM, Zhang L, Beitelshees AL, Berenson GS, Bhatt DL, Boer JM, Boerwinkle E, Burkley B, Burt A, Chakravarti A, Chen W, Cooper-Dehoff RM, Curtis SP, Dreisbach A, Duggan D, Ehret GB, Fabsitz RR, Fornage M, Fox E, Furlong CE, Gansevoort RT, Hofker MH, Hovingh GK, Kirkland SA, Kottke-Marchant K, Kutlar A, Lacroix AZ, Langaee TY, Li YR, Lin H, Liu K, Maiwald S, Malik R; CARDIOGRAM, METASTROKE, Murugesan G, Newton-Cheh C, O'Connell JR, Onland-Moret NC, Ouwehand WH, Palmas W, Penninx BW, Pepine CJ, Pettinger M, Polak JF, Ramachandran VS, Ranchalis J, Redline S, Ridker PM, Rose LM, Scharnag H, Schork NJ, Shimbo D, Shuldiner AR, Srinivasan SR, Stolk RP, Taylor HA, Thorand B, Trip MD, van Duijn CM, Verschuren WM, Wijmenga C, Winkelmann BR, Wyatt S, Young JH, Boehm BO, Caulfield MJ, Chasman DI, Davidson KW, Doevendans PA, Fitzgerald GA, Gums JG, Hakonarson H, Hillege HL, Illig T, Jarvik GP, Johnson JA, Kastelein JJ, Koenig W; LifeLines Cohort Study, März W, Mitchell BD, Murray SS, Oldehinkel AJ, Rader DJ, Reilly MP, Reiner AP, Schadt EE, Silverstein RL, Snieder H, Stanton AV, Uitterlinden AG, van der Harst P, van der Schouw YT, Samani NJ, Johnson AD, Munroe PB, de Bakker PI, Zhu X, Levy D, Keating BJ, Asselbergs FW.

Hum Mol Genet. 2013 Apr 15;22(8):1663-78. doi: 10.1093/hmg/dds555. Epub 2013 Jan 8. Erratum in: Hum Mol Genet. 2013 Aug 15;22(16):3394-5. Van Setten, Jessic A [corrected to Van Setten, Jessica].

26.

Protein adducts as biomarkers of exposure to organophosphorus compounds.

Marsillach J, Costa LG, Furlong CE.

Toxicology. 2013 May 10;307:46-54. doi: 10.1016/j.tox.2012.12.007. Epub 2012 Dec 20. Review.

27.

Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.

Kim DS, Burt AA, Crosslin DR, Robertson PD, Ranchalis JE, Boyko EJ, Nickerson DA, Furlong CE, Jarvik GP.

J Lipid Res. 2013 Feb;54(2):552-60. doi: 10.1194/jlr.P033266. Epub 2012 Nov 15.

28.

Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures.

Marsillach J, Hsieh EJ, Richter RJ, MacCoss MJ, Furlong CE.

Chem Biol Interact. 2013 Mar 25;203(1):85-90. doi: 10.1016/j.cbi.2012.10.019. Epub 2012 Nov 2.

29.

Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.

Baker PE, Cole TB, Cartwright M, Suzuki SM, Thummel KE, Lin YS, Co AL, Rettie AE, Kim JH, Furlong CE.

Chem Biol Interact. 2013 Mar 25;203(1):257-64. doi: 10.1016/j.cbi.2012.10.005. Epub 2012 Oct 22.

30.

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.

Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW, Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O'Connell JR, Padmanabhan S, Pankow JS, Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN, Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR, Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff RM, Cupples LA, deJong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG, Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, Kottke-Marchant K, Kumari M, LaCroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS, Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP, Swerdlow DI, Taylor HA Jr, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC, Zwinderman AH; LifeLines Cohort Study, Anand SS, Balmforth AJ, Berenson GS, Bezzina CR, Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ, Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA, Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM, Kathiresan S, Koenig W, Lawlor DA, März W, Melander O, Mitchell BD, Montgomery GW, Munroe PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI, Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA, Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG, Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ, Hakonarson H, Elbers CC, Keating BJ, Drenos F.

Am J Hum Genet. 2012 Nov 2;91(5):823-38. doi: 10.1016/j.ajhg.2012.08.032. Epub 2012 Oct 11.

31.

Dietary cholesterol increases paraoxonase 1 enzyme activity.

Kim DS, Burt AA, Ranchalis JE, Richter RJ, Marshall JK, Nakayama KS, Jarvik ER, Eintracht JF, Rosenthal EA, Furlong CE, Jarvik GP.

J Lipid Res. 2012 Nov;53(11):2450-8. doi: 10.1194/jlr.P030601. Epub 2012 Aug 15.

32.

Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE.

Toxicology. 2013 May 10;307:115-22. doi: 10.1016/j.tox.2012.07.011. Epub 2012 Jul 31. Review.

33.

Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.

Kim DS, Burt AA, Ranchalis JE, Richter RJ, Marshall JK, Eintracht JF, Rosenthal EA, Furlong CE, Jarvik GP.

J Lipids. 2012;2012:476316. doi: 10.1155/2012/476316. Epub 2012 May 22.

34.

Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.

Cole TB, Fisher JC, Burbacher TM, Costa LG, Furlong CE.

Neurotoxicol Teratol. 2012 May-Jun;34(3):311-22. doi: 10.1016/j.ntt.2012.02.003. Epub 2012 Mar 7.

35.

Immunosensor towards low-cost, rapid diagnosis of tuberculosis.

Kim JH, Yeo WH, Shu Z, Soelberg SD, Inoue S, Kalyanasundaram D, Ludwig J, Furlong CE, Riley JJ, Weigel KM, Cangelosi GA, Oh K, Lee KH, Gao D, Chung JH.

Lab Chip. 2012 Apr 21;12(8):1437-40. doi: 10.1039/c2lc21131a. Epub 2012 Mar 6.

PMID:
22395572
36.

Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.

Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, Lanktree MB, Tare A, Castillo BA, Li YR, Johnson T, Bruinenberg M, Gilbert-Diamond D, Rajagopalan R, Voight BF, Balasubramanyam A, Barnard J, Bauer F, Baumert J, Bhangale T, Böhm BO, Braund PS, Burton PR, Chandrupatla HR, Clarke R, Cooper-DeHoff RM, Crook ED, Davey-Smith G, Day IN, de Boer A, de Groot MC, Drenos F, Ferguson J, Fox CS, Furlong CE, Gibson Q, Gieger C, Gilhuijs-Pederson LA, Glessner JT, Goel A, Gong Y, Grant SF, Grobbee DE, Hastie C, Humphries SE, Kim CE, Kivimaki M, Kleber M, Meisinger C, Kumari M, Langaee TY, Lawlor DA, Li M, Lobmeyer MT, Maitland-van der Zee AH, Meijs MF, Molony CM, Morrow DA, Murugesan G, Musani SK, Nelson CP, Newhouse SJ, O'Connell JR, Padmanabhan S, Palmen J, Patel SR, Pepine CJ, Pettinger M, Price TS, Rafelt S, Ranchalis J, Rasheed A, Rosenthal E, Ruczinski I, Shah S, Shen H, Silbernagel G, Smith EN, Spijkerman AW, Stanton A, Steffes MW, Thorand B, Trip M, van der Harst P, van der A DL, van Iperen EP, van Setten J, van Vliet-Ostaptchouk JV, Verweij N, Wolffenbuttel BH, Young T, Zafarmand MH, Zmuda JM; Look AHEAD Research Group; DIAGRAM consortium, Boehnke M, Altshuler D, McCarthy M, Kao WH, Pankow JS, Cappola TP, Sever P, Poulter N, Caulfield M, Dominiczak A, Shields DC, Bhatt DL, Zhang L, Curtis SP, Danesh J, Casas JP, van der Schouw YT, Onland-Moret NC, Doevendans PA, Dorn GW 2nd, Farrall M, FitzGerald GA, Hamsten A, Hegele R, Hingorani AD, Hofker MH, Huggins GS, Illig T, Jarvik GP, Johnson JA, Klungel OH, Knowler WC, Koenig W, März W, Meigs JB, Melander O, Munroe PB, Mitchell BD, Bielinski SJ, Rader DJ, Reilly MP, Rich SS, Rotter JI, Saleheen D, Samani NJ, Schadt EE, Shuldiner AR, Silverstein R, Kottke-Marchant K, Talmud PJ, Watkins H, Asselbergs FW, de Bakker PI, McCaffery J, Wijmenga C, Sabatine MS, Wilson JG, Reiner A, Bowden DW, Hakonarson H, Siscovick DS, Keating BJ.

Am J Hum Genet. 2012 Mar 9;90(3):410-25. doi: 10.1016/j.ajhg.2011.12.022. Epub 2012 Feb 9. Erratum in: Am J Hum Genet. 2012 Apr 6;90(4):753. Sever, Peter [added]; Poulter, Neil [added] Bhatt, Deepak [corrected to Bhatt, Deepak L]; Asselbergs, Folkert [corrected to Asselbergs, Folkert W].

37.

The relationship between Gulf War illness, brain N-acetylaspartate, and post-traumatic stress disorder.

Weiner MW, Meyerhoff DJ, Neylan TC, Hlavin J, Ramage ER, McCoy D, Studholme C, Cardenas V, Marmar C, Truran D, Chu PW, Kornak J, Furlong CE, McCarthy C.

Mil Med. 2011 Aug;176(8):896-902.

38.

Biomarkers of organophosphorus (OP) exposures in humans.

Marsillach J, Richter RJ, Kim JH, Stevens RC, MacCoss MJ, Tomazela D, Suzuki SM, Schopfer LM, Lockridge O, Furlong CE.

Neurotoxicology. 2011 Oct;32(5):656-60. doi: 10.1016/j.neuro.2011.06.005. Epub 2011 Jul 8.

39.

Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.

Liyasova M, Li B, Schopfer LM, Nachon F, Masson P, Furlong CE, Lockridge O.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):337-47. doi: 10.1016/j.taap.2011.06.016. Epub 2011 Jun 24.

40.

Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.

Cole TB, Beyer RP, Bammler TK, Park SS, Farin FM, Costa LG, Furlong CE.

Toxicol Sci. 2011 Sep;123(1):155-69. doi: 10.1093/toxsci/kfr157. Epub 2011 Jun 14.

41.

Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Giordano G, Cole TB, Furlong CE, Costa LG.

Toxicol Appl Pharmacol. 2011 Nov 1;256(3):369-78. doi: 10.1016/j.taap.2011.02.014. Epub 2011 Feb 23.

42.

Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.

Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, Pankratz N, Pankow JS, Shah S, Taylor K, Barnard J, Peters BJ, Maloney CM, Lobmeyer MT, Stanton A, Zafarmand MH, Romaine SP, Mehta A, van Iperen EP, Gong Y, Price TS, Smith EN, Kim CE, Li YR, Asselbergs FW, Atwood LD, Bailey KM, Bhatt D, Bauer F, Behr ER, Bhangale T, Boer JM, Boehm BO, Bradfield JP, Brown M, Braund PS, Burton PR, Carty C, Chandrupatla HR, Chen W, Connell J, Dalgeorgou C, Boer Ad, Drenos F, Elbers CC, Fang JC, Fox CS, Frackelton EC, Fuchs B, Furlong CE, Gibson Q, Gieger C, Goel A, Grobbee DE, Hastie C, Howard PJ, Huang GH, Johnson WC, Li Q, Kleber ME, Klein BE, Klein R, Kooperberg C, Ky B, Lacroix A, Lanken P, Lathrop M, Li M, Marshall V, Melander O, Mentch FD, Meyer NJ, Monda KL, Montpetit A, Murugesan G, Nakayama K, Nondahl D, Onipinla A, Rafelt S, Newhouse SJ, Otieno FG, Patel SR, Putt ME, Rodriguez S, Safa RN, Sawyer DB, Schreiner PJ, Simpson C, Sivapalaratnam S, Srinivasan SR, Suver C, Swergold G, Sweitzer NK, Thomas KA, Thorand B, Timpson NJ, Tischfield S, Tobin M, Tomaszewski M, Verschuren WM, Wallace C, Winkelmann B, Zhang H, Zheng D, Zhang L, Zmuda JM, Clarke R, Balmforth AJ, Danesh J, Day IN, Schork NJ, de Bakker PI, Delles C, Duggan D, Hingorani AD, Hirschhorn JN, Hofker MH, Humphries SE, Kivimaki M, Lawlor DA, Kottke-Marchant K, Mega JL, Mitchell BD, Morrow DA, Palmen J, Redline S, Shields DC, Shuldiner AR, Sleiman PM, Smith GD, Farrall M, Jamshidi Y, Christiani DC, Casas JP, Hall AS, Doevendans PA, Christie JD, Berenson GS, Murray SS, Illig T, Dorn GW 2nd, Cappola TP, Boerwinkle E, Sever P, Rader DJ, Reilly MP, Caulfield M, Talmud PJ, Topol E, Engert JC, Wang K, Dominiczak A, Hamsten A, Curtis SP, Silverstein RL, Lange LA, Sabatine MS, Trip M, Saleheen D, Peden JF, Cruickshanks KJ, März W, O'Connell JR, Klungel OH, Wijmenga C, Maitland-van der Zee AH, Schadt EE, Johnson JA, Jarvik GP, Papanicolaou GJ; Hugh Watkins on behalf of PROCARDIS, Grant SF, Munroe PB, North KE, Samani NJ, Koenig W, Gaunt TR, Anand SS, van der Schouw YT; Meena Kumari on behalf of the Whitehall II Study and the WHII 50K Group, Soranzo N, Fitzgerald GA, Reiner A, Hegele RA, Hakonarson H, Keating BJ.

Am J Hum Genet. 2011 Jan 7;88(1):6-18. doi: 10.1016/j.ajhg.2010.11.007. Epub 2010 Dec 30. Erratum in: Am J Hum Genet. 2012 Jun 8;90(6):1117. Tomaszweski, Maciej [corrected to Tomaszewski, Maciej].

43.

Exposure to triaryl phosphates: metabolism and biomarkers of exposure.

Furlong CE.

J Biol Phys Chem. 2011;11. doi: 10.4024/28FU11A.jbpc.11.04.

44.

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Costa LG, Giordano G, Furlong CE.

Biochem Pharmacol. 2011 Feb 1;81(3):337-44. doi: 10.1016/j.bcp.2010.11.008. Epub 2010 Nov 18. Review.

45.

Paraoxonase gene mutations in amyotrophic lateral sclerosis.

Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silani V, Furlong CE, Brown RH Jr, Landers JE.

Ann Neurol. 2010 Jul;68(1):102-7. doi: 10.1002/ana.21993.

46.

Development of diagnostics in the search for an explanation of aerotoxic syndrome.

Schopfer LM, Furlong CE, Lockridge O.

Anal Biochem. 2010 Sep 1;404(1):64-74. doi: 10.1016/j.ab.2010.04.032. Epub 2010 May 4.

47.

Human PON1, a biomarker of risk of disease and exposure.

Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, Checkoway H, Samii A, Costa LG, Griffith A, Roberts JW, Yearout D, Zabetian CP.

Chem Biol Interact. 2010 Sep 6;187(1-3):355-61. doi: 10.1016/j.cbi.2010.03.033. Epub 2010 Mar 23. Review.

48.

Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides.

Mackenzie Ross SJ, Brewin CR, Curran HV, Furlong CE, Abraham-Smith KM, Harrison V.

Neurotoxicol Teratol. 2010 Jul-Aug;32(4):452-9. doi: 10.1016/j.ntt.2010.03.004. Epub 2010 Mar 20.

49.

Identification and characterization of biomarkers of organophosphorus exposures in humans.

Kim JH, Stevens RC, MacCoss MJ, Goodlett DR, Scherl A, Richter RJ, Suzuki SM, Furlong CE.

Adv Exp Med Biol. 2010;660:61-71. doi: 10.1007/978-1-60761-350-3_7. Review.

50.

The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Cole TB, Jansen K, Park S, Li WF, Furlong CE, Costa LG.

Adv Exp Med Biol. 2010;660:47-60. doi: 10.1007/978-1-60761-350-3_6. Review.

Supplemental Content

Loading ...
Support Center